Search
Innovative Drug Funds Shine in Public Fund Half-Year Earnings, Underscoring Allocation Value
2 day ago /
Read about 0 minute
Author：小编
The public fund performance rankings for the first half of the year reveal a dominant trend: medical funds led the market, boasting an average net value growth rate exceeding 19%, and occupying 49 spots on the top 100 list. Notably, innovative drug-themed funds have stood out with an impressive average net value growth rate of up to 27.68% this year. This outstanding performance can be attributed to several factors, including robust policy support, the accelerated transformation of R&D achievements, and the ongoing restructuring of the global pharmaceutical industry chain. Many fund managers are confident in the attractive valuation and robust growth potential of the innovative drug sector.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
